Lysosomal transport

pathway activity & survival
GO:0007041SurvivalRNA activityKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNA activity of the Lysosomal transport pathway is associated with patient survival in 24 of 34 cancer lineages. Pathway activity is summarized from the expression of its 133 member genes.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher Lysosomal transport pathway activity is associated with better disease-free survival. In most high-consensus cancer types, elevated pathway activity shows an unfavorable survival association, although some cancer types, such as HNSC and BRCA, show the opposite pattern, with higher activity associated with better survival.

HNSC, KIRC, and BRCA are the cancer lineages in which this pathway most reproducibly stratifies patient survival.

Pathway-activity survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 represent the survival AUCs for the high- and low-pathway-activity groups, respectively. The group with the lower AUC is interpreted as having poorer survival. The reported p-values are derived from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCDFSMedianII,III,IV0.4220.255<.001137view →
KIRCDFSTertileAll0.5040.676.00147view →
BRCADFSQuartileIII,IV0.9650.782<.00147view →
UCSDFSMedianIV0.9520.473.01836view →
UVMDFSQuartileIII,IV0.1870.844.00234view →
ESCAOSMedianIII,IV0.6540.317.00233view →
LUSCDFSMedianIII,IV0.3420.997<.00133view →
SCLCDFSQuartileIII,IV0.7160.240.00619view →
UCECOSMedianIV0.9360.614.00918view →
SKCMOSQuartileIII,IV0.4850.208.00815view →
SARCOSQuartileAll0.6470.408.00514view →
MESODFSMedianIV0.2420.483.03014view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

GO:0007041–HNSC (DFS)

Kaplan–Meier survival curve for Lysosomal transport pathway activity in HNSC.

Open the HNSC breakdown →

Exploration